Dr. Mosconi brings more than 25 years of experience in the biopharmaceutical industry. He advice International pharma, biotech, Venture capital and Investing companies , sit in Board of Directors companies of Dipharma SA and Formula Pharma . He was Vice President and chief of R&D at Gentium Gmbh based in Switzerland for the development and EMA approval of Defitelio ( acquired by Jazz Pharmaceuticals) . He spent 14 years in USA where he co-founded Formula Pharma in Philadelphia area, was President and Chief Operating Officer at Acureon, a search fund supported by three major U.S. VCs. Prior to this, he served as Senior Vice President, Business Development, at Vicuron Pharmaceuticals, Inc. USA (acquired by Pfizer in 2005), the result of a merger between Biosearch Italia and Versicor Inc. Previously, Dr. Mosconi served as Vice President, Medical Affairs and Business Development at Biosearch Italia and as European Executive Director for R&D Anti-infectives and Immunology at Bristol-Myers-Squibb in Belgium . Dr. Mosconi began his career at Marion Merrell Dow (now Sanofi-aventis) serving as Italian Medical Leader, Anti-infectives, and then transitioning to European Therapeutic Leader in Zurich. He earned his M.D. from the Medical School University of Milan and his Ph.D. in ENT, head and neck surgery from the University of Milan. He holds a B.A. in chemistry. He also co founded NeED Foundation a non profit Organization against counterfeit drug traffic in the third world.